Physician profile
Lin Wang
NPI 1700187515
$9,746.57
in general payments reported to CMS, 2019-2025
8 companies · $482 in 2025
The $482 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $236 · 2021: $183 · 2022: $1,561 · 2023: $2,527 · 2024: $3,972 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,455 · Food and Beverage: $2,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,454.59 |
| Food and Beverage | $2,526.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,432.13 | 2021-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,115.53 | 2020-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Siemens Medical Solutions USA, INC. | $1,711.96 | 2023 | Naeotom Alpha |
| Medtronic, INC. | $1,476.89 | 2022-2025 | Apollotm, Symplicity G3, Corevalve Evolut R |
| Artivion, INC. | $1,061.26 | 2024 | Cardiac Non-Synergraft |
| Medtronic Vascular, INC. | $622.99 | 2019 | |
| Boston Scientific Corporation | $306.67 | 2019-2023 | Spaceoar System |
| Merck Sharp & Dohme LLC | $19.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.